| Steve Lovelady Md Llc | |
|
1490 N Bank Pkwy Ste 290 Tuscaloosa AL 35406-2430 | |
| (205) 523-7001 | |
| Not Available |
| Full Name | Steve Lovelady Md Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 1490 N Bank Pkwy Ste 290, Tuscaloosa, Alabama |
| Authorized Official Name and Position | Stephen Lovelady (OFFICE MANAGER) |
| Authorized Official Contact | 2054543926 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Steve Lovelady Md Llc 315 Main Ave Northport AL 35476-5057 Ph: (205) 523-7001 | Steve Lovelady Md Llc 1490 N Bank Pkwy Ste 290 Tuscaloosa AL 35406-2430 Ph: (205) 523-7001 |
| NPI Number | 1013465988 |
|---|---|
| Provider Enumeration Date | 09/20/2016 |
| Last Update Date | 09/20/2016 |
| Medicare PECOS PAC ID | 5698057552 |
|---|---|
| Medicare Enrollment ID | O20170130000923 |
News Archive
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's subsidiary, CardioGenics Inc., has entered into an agreement with Merck Chimie S.A.S. to adopt its proprietary biological-linking technology to Merck-supplied magnetic beads designed to increase yields in antibody manufacturing.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013465988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | 11421 (Alabama) | Primary |
| Provider Name | Steve R Lovelady |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295801579 PECOS PAC ID: 1951397256 Enrollment ID: I20040422000577 |
News Archive
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's subsidiary, CardioGenics Inc., has entered into an agreement with Merck Chimie S.A.S. to adopt its proprietary biological-linking technology to Merck-supplied magnetic beads designed to increase yields in antibody manufacturing.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
› Verified 3 days ago
News Archive
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's subsidiary, CardioGenics Inc., has entered into an agreement with Merck Chimie S.A.S. to adopt its proprietary biological-linking technology to Merck-supplied magnetic beads designed to increase yields in antibody manufacturing.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
› Verified 3 days ago
West Alabama Physician Associates Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 701 University Blvd E Ste 211, Tuscaloosa, AL 35401 Phone: 205-333-4965 | |
Alabama Hospital Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-344-9019 Fax: 205-344-9036 | |
Five Horizons Health Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2720 6th St, Tuscaloosa, AL 35401 Phone: 205-759-8470 Fax: 205-366-9001 | |
Whatley Health Services, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2731 Martin Luther King Blvd, Tuscaloosa, AL 35401 Phone: 205-349-3250 Fax: 205-752-1517 | |
Mentorup Life Lab & Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 535 Jack Warner Pkwy Ne Ste G2, Tuscaloosa, AL 35404 Phone: 205-771-2261 | |
Maude L. Whatley Health Centers Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2731 Mlk Jr Blvd, Tuscaloosa, AL 35401 Phone: 205-349-3250 Fax: 205-345-3993 |